<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02910765</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00009906</org_study_id>
    <nct_id>NCT02910765</nct_id>
  </id_info>
  <brief_title>Methylene Blue and Ozone in Early Sepsis</brief_title>
  <official_title>Methylene Blue and Ozone in Early Sepsis , a Randomized Double Blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      effects of methylene blue and ozone O3 therapy effects in early sepsis management , and their
      implications upon outcome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      effects of methylene blue on inducible nitric oxide messenger RNA transcription and protein
      expression are well evident in vasoplegia ,and septic shock . In the same time , ozone O3
      therapy is also valuable in immune-modulation in multiple pathologies . our study collaborate
      both methylene blue and Ozone in early sepsis management , and we will evaluate the global
      medical progress , ICU stay , Morbidity and mortality
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>APACHE score</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>M methylene blue and ozone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intravenous methylene blue and blood mixed with ozone ozone injection in early sepsis patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>P Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline and oxygen mixed blood injection in early sepsis patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylene blue</intervention_name>
    <arm_group_label>M methylene blue and ozone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ozone</intervention_name>
    <arm_group_label>M methylene blue and ozone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline infusion</intervention_name>
    <arm_group_label>P Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxygen</intervention_name>
    <arm_group_label>P Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  early sepsis Adults patients

        Exclusion Criteria:

          -  cardiac problems Glucose-6-Phosphate-Dehydrogenase Insufficiency Ozone Allergy Recent
             Myocardial Infarction Active Hyperthyroidism Thrombocytopenia Pregnancy
             Contraindications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emad Zarief K Said, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emad Zarief K. Said, MD</last_name>
    <phone>00201007046058</phone>
    <email>emadzarief@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abdelraheem Elawamy, MD</last_name>
    <phone>00201000032655</phone>
  </overall_contact_backup>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2016</study_first_posted>
  <last_update_submitted>September 20, 2016</last_update_submitted>
  <last_update_submitted_qc>September 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Emad Zarief , MD</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia and critical care Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylene Blue</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

